| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Biochemistry [T. S., A. T., K. Y., Y. N.], Pathology [F. A., G. S.], and Surgery [F. K.], Cancer Institute, Tokyo, 1-37-1, Kami-Ikebukuro, Toshima-ku, Tokyo 170, Japan
Allele loss on a specific chromosome has implied the existence of a tumor suppressor gene such as the p53 gene and the RB gene. In order to determine which chromsome(s) carries a tumor suppressor gene(s) that contributes to tumor progression in primary breast cancer, we analyzed the loss of heterozygosity for each autosomal chromosome arm by using 39 restriction fragment length polymorphism markers including 25 variable numbers of tandem repeat probes. In 79 primary breast cancers, we found the frequent loss on the long arm of chromosome 13 (21%), the long arm of chromosome 16 (45%), and the short arm of chromosome 17 (56%). Interestingly, breast cancers in which loss of both chromosomes 13q and 17p was detected showed more malignant histopathological features, and a group of the tumors in which chromosome 16q loss was detected presented with frequent lymph node metastasis. Furthermore, the result of the deletion mapping on chromosome 17p implied the existence of a tumor suppressor gene distal to the p53 gene as well as the p53 gene itself for primary breast cancer. These results suggest that at least 4 tumor suppressor genes exist on chromosomes 13q, 16q, and 17p for primary breast cancer.
1 The work was supported in part by a grant from Uehara Memorial Foundation.
2 To whom requests for reprints should be addressed, at Department of Biochemistry, Cancer Institute, Tokyo. 1-37-1, Kami-Ikebukuro, Toshima-ku, Tokyo 170, Japan.
Received 5/29/90. Accepted 8/14/90.
This article has been cited by other articles:
|
|
 |
|
  A. K. Bauer, A. M. Malkinson, and S. R. Kleeberger Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L685 - L703. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Fernando, E. Sasatomi, N. A. Christie, P. O. Buenaventura, S. D. Finkelstein, S. A. Yousem, R. Soose, J. M. Close, and J. D. Luketich Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: A pilot study J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 87 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Amari, T. Moriya, T. Ishida, Y. Harada, K. Ohnuki, M. Takeda, H. Sasano, A. Horii, and N. Ohuchi Loss of Heterozygosity Analyses of Asynchronous Lesions of Ductal Carcinoma in situ and Invasive Ductal Carcinoma of the Human Breast Jpn. J. Clin. Oncol., November 1, 2003; 33(11): 556 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Seril, J. Liao, G.-Y. Yang, and C. S. Yang Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models Carcinogenesis, March 1, 2003; 24(3): 353 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tsuda, T. Takarabe, Y. Kanai, T. Fukutomi, and S. Hirohashi Correlation of DNA Hypomethylation at Pericentromeric Heterochromatin Regions of Chromosomes 16 and 1 with Histological Features and Chromosomal Abnormalities of Human Breast Carcinomas Am. J. Pathol., September 1, 2002; 161(3): 859 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kokudo, Y. Miki, S. Sugai, A. Yanagisawa, Y. Kato, Y. Sakamoto, J. Yamamoto, T. Yamaguchi, T. Muto, and M. Makuuchi Genetic and Histological Assessment of Surgical Margins in Resected Liver Metastases From Colorectal Carcinoma: Minimum Surgical Margins for Successful Resection Arch Surg, July 1, 2002; 137(7): 833 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sasatomi, S. D. Finkelstein, J. D. Woods, A. Bakker, P. A. Swalsky, J. D. Luketich, H. C. Fernando, and S. A. Yousem Comparison of Accumulated Allele Loss between Primary Tumor and Lymph Node Metastasis in Stage II Non-small Cell Lung Carcinoma: Implications for the Timing of Lymph Node Metastasis and Prognostic Value Cancer Res., May 1, 2002; 62(9): 2681 - 2689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Sargent, J. R. Senft, D. T. Lowry, A. M. Jefferson, F. L. Tyson, A. M. Malkinson, A. E. Coleman, and S. H. Reynolds Specific Chromosomal Aberrations in Mouse Lung Adenocarcinoma Cell Lines Detected by Spectral Karyotyping: A Comparison with Human Lung Adenocarcinoma Cancer Res., February 1, 2002; 62(4): 1152 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Wild, P. Langer, A. Ramaswamy, B. Chaloupka, and D. K. Bartsch A Novel Insulinoma Tumor Suppressor Gene Locus on Chromosome 22q with Potential Prognostic Implications J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5782 - 5787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rolston, E. Sasatomi, J. Hunt, P. A. Swalsky, and S. D. Finkelstein Distinguishing de Novo Second Cancer Formation from Tumor Recurrence: Mutational Fingerprinting by Microdissection Genotyping J. Mol. Diagn., November 1, 2001; 3(4): 129 - 132. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tsuneizumi, M. Emi, H. Nagai, H. Harada, G. Sakamoto, F. Kasumi, S. Inoue, T. Kazui, and Y. Nakamura Overrepresentation of the EBAG9 Gene at 8q23 Associated with Early-Stage Breast Cancers Clin. Cancer Res., November 1, 2001; 7(11): 3526 - 3532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Roy, G. Calaf, and T. K. Hei Frequent allelic imbalance on chromosome 6 and 17 correlate with radiation-induced neoplastic transformation of human breast epithelial cells Carcinogenesis, October 1, 2001; 22(10): 1685 - 1692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Maniwa, M. Yoshimura, C. Obayashi, M. Inaba, K. Kiyooka, M. Kanki, and Y. Okita Association of p53 Gene Mutation and Telomerase Activity in Resectable Non-Small Cell Lung Cancer Chest, August 1, 2001; 120(2): 589 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hirano, M. Emi, M. Tsuneizumi, Y. Utada, M. Yoshimoto, F. Kasumi, F. Akiyama, G. Sakamoto, S. Haga, T. Kajiwara, et al. Allelic Losses of Loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 Correlate with Postoperative Recurrence in Breast Cancer Clin. Cancer Res., April 1, 2001; 7(4): 876 - 882. [Abstract] [Full Text]
|
|
|
|
|
|
X. Yang, L. Wei, C. Tang, R. Slack, E. Montgomery, and M. Lippman KAI1 Protein Is Down-Regulated during the Progression of Human Breast Cancer Clin. Cancer Res., September 1, 2000; 6(9): 3424 - 3429. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Mei, P. C. Galipeau, C. Prass, A. Berno, G. Ghandour, N. Patil, R. K. Wolff, M. S. Chee, B. J. Reid, and D. J. Lockhart Genome-wide Detection of Allelic Imbalance Using Human SNPs and High-density DNA Arrays Genome Res., August 1, 2000; 10(8): 1126 - 1137. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Utada, M. Emi, M. Yoshimoto, F. Kasumi, F. Akiyama, G. Sakamoto, S. Haga, T. Kajiwara, and Y. Nakamura Allelic Loss at 1p34-36 Predicts Poor Prognosis in Node-negative Breast Cancer Clin. Cancer Res., August 1, 2000; 6(8): 3193 - 3198. [Abstract] [Full Text]
|
|
|
|
|
|
P. W. Schlosshauer, S. A. Brown, K. Eisinger, Q. Yan, E. R. Guglielminetti, R. Parsons, L. H. Ellenson, and J. Kitajewski APC truncation and increased {beta}-catenin levels in a human breast cancer cell line Carcinogenesis, July 1, 2000; 21(7): 1453 - 1456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Castells, J. F. Gusella, V. Ramesh, and A. K. Rustgi A Region of Deletion on Chromosome 22q13 Is Common to Human Breast and Colorectal Cancers Cancer Res., June 1, 2000; 60(11): 2836 - 2839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hosono, I. Gross, M. A. English, K. M. Hajra, E. R. Fearon, and J. D. Licht E-cadherin Is a WT1 Target Gene J. Biol. Chem., April 6, 2000; 275(15): 10943 - 10953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Bednarek, K. J. Laflin, R. L. Daniel, Q. Liao, K. A. Hawkins, and C. M. Aldaz WWOX, a Novel WW Domain-containing Protein Mapping to Human Chromosome 16q23.3-24.1, a Region Frequently Affected in Breast Cancer Cancer Res., April 1, 2000; 60(8): 2140 - 2145. [Abstract] [Full Text]
|
|
|
|
|
|
X. Cui, H. Feiner, Z. Lin, and H. Li Multiplex Genotype Analysis of Invasive Carcinoma and Accompanying Proliferative Lesions Microdissected from Breast Tissue J. Mol. Diagn., February 1, 2000; 2(1): 29 - 36. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Daigo, Y. Furukawa, T. Kawasoe, H. Ishiguro, M. Fujita, S. Sugai, S. Nakamori, G.-J. Liefers, R. A. E. M. Tollenaar, C. J. H. van de Velde, et al. Absence of Genetic Alteration at Codon 531 of the Human c-src Gene in 479 Advanced Colorectal Cancers from Japanese and Caucasian Patients Cancer Res., September 1, 1999; 59(17): 4222 - 4224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Sargent, X. Zhou, C. L. Keck, N. D. Sanderson, D. B. Zimonjic, N. C. Popescu, and S. S. Thorgeirsson Nonrandom Cytogenetic Alterations in Hepatocellular Carcinoma from Transgenic Mice Overexpressing c-Myc and Transforming Growth Factor-{alpha} in the Liver Am. J. Pathol., April 1, 1999; 154(4): 1047 - 1055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Durbin, M. R. Novelli, and W. F. Bodmer Genomic and cDNA sequence analysis of the cell matrix adhesion regulator gene PNAS, December 23, 1997; 94(26): 14578 - 14583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Extended Abstracts Toxicol Pathol, November 1, 1997; 25(6): 674 - 696. [PDF]
|
|
|
|
 |
|
 P. Robbins p53 and Breast Cancer International Journal of Surgical Pathology, October 1, 1996; 4(2): 93 - 110. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Futreal, Q Liu, D Shattuck-Eidens, C Cochran, K Harshman, S Tavtigian, L. Bennett, A Haugen-Strano, J Swensen, Y Miki, et al. BRCA1 mutations in primary breast and ovarian carcinomas Science, October 7, 1994; 266(5182): 120 - 122. [Abstract] [PDF]
|
|
|
|
 |
|
 W.B. Isaacs, G.S. Bova, R.A. Morton, M.J.G. Bussemakers, J.D. Brooks, and C.M. Ewing Genetic Alterations in Prostate Cancer Cold Spring Harb Symp Quant Biol, January 1, 1994; 59(0): 653 - 659. [Abstract] [PDF]
|
|
|
|
 |
|
 G J Hannon, D Demetrick, and D Beach Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes & Dev., December 1, 1993; 7(12a): 2378 - 2391. [Abstract] [PDF]
|
|
|
|
 |
|
 C. C. Harris and M. Hollstein Clinical Implications of the p53 Tumor-Suppressor Gene N. Engl. J. Med., October 28, 1993; 329(18): 1318 - 1327. [Full Text]
|
|
|
|
|
|
A Kallioniemi, O. Kallioniemi, D Sudar, D Rutovitz, J. Gray, F Waldman, and D Pinkel Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors Science, October 30, 1992; 258(5083): 818 - 821. [Abstract] [PDF]
|
|
|
|
|
|
E Solomon, J Borrow, and A. Goddard Chromosome aberrations and cancer Science, November 22, 1991; 254(5035): 1153 - 1160. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
